Form 4 for DGX Quest Diagnostics
Accepted 2024-10-30 00:00:00 ET · period of report 2024-10-28 · accession 0001022079-24-000202 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-30 | 2024-10-28 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | S - Sale | $156.92 | -1,775 | 9,734 | -15% | -$278.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-28 | S | D | 1,775 | $156.92 | 9,734 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $156.830 to $156.9156. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |